Please login to the form below

Not currently logged in
Email:
Password:

Synergy Vision wins gold Investors in People accreditation

Agency upgraded from silver to gold status

SV

London, UK-based medical communications agency Synergy Vision has been granted gold accreditation status from Investors in People (IIP).

IIP said the agency “works effectively together to deliver the difference to its clients that will positively affect patient care”.

Synergy was first awarded Core IIP accreditation back in 2011, which was upgraded to silver in 2013 and now the group has acquired gold status. The progression in IIP status reflects on how a company’s career development, and reward and recognition programmes have developed over the years.

Ffyona Dawber, Synergy Vision’s managing director, said: “We realise that our team is Synergy Vision’s greatest asset.

“It’s so important to invest in making sure everyone - through all levels of the company - enjoys their work and can progress into new roles whenever they are ready.

“We are happy to see that the IIP assessment has recognised the efforts we put into making our team happy.”

Last year the agency was the highest placed medical communications agency in the UK’s Best Workplaces: Small Category awards.

Article by
Gemma Jones

12th May 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics